These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25277427)

  • 21. Canine embryonic stem cells: state of the art.
    Schneider MR; Wolf E; Braun J; Kolb HJ; Adler H
    Theriogenology; 2010 Sep; 74(4):492-7. PubMed ID: 19963261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promises and challenges of stem cell research for regenerative medicine.
    Power C; Rasko JE
    Ann Intern Med; 2011 Nov; 155(10):706-13, W217. PubMed ID: 22084335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIOETHICS SYMPOSIUM II: current factors influencing perceptions of animals and their welfare.
    McKendree MG; Croney CC; Olynk Widmar NJ
    J Anim Sci; 2014 May; 92(5):1821-31. PubMed ID: 24671600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global update: Germany.
    Lauter FR; Wirsching S
    Regen Med; 2011 Nov; 6(6 Suppl):154-7. PubMed ID: 21999280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease.
    Borjesson DL; Peroni JF
    Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in stem cells and regenerative medicine].
    Wang L; Zhu H; Hao J; Zhou Q
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):871-9. PubMed ID: 26672363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
    Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
    Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regenerative medicine: history and perspectives].
    Okabayashi K; Asashima M
    Nihon Rinsho; 2008 May; 66(5):825-30. PubMed ID: 18464498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human pluripotent stem cells: decoding the naïve state.
    Li W; Ding S
    Sci Transl Med; 2011 Mar; 3(76):76ps10. PubMed ID: 21451122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ES and iPS cell research for cardiovascular regeneration.
    Yamashita JK
    Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation of cat embryonic stem-like cells from in vitro-produced blastocysts on homologous and heterologous feeder cells.
    Gómez MC; Serrano MA; Pope CE; Jenkins JA; Biancardi MN; López M; Dumas C; Galiguis J; Dresser BL
    Theriogenology; 2010 Sep; 74(4):498-515. PubMed ID: 20708127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directed embryonic stem cell differentiation with small molecules.
    Zhu S; Wurdak H; Schultz PG
    Future Med Chem; 2010 Jun; 2(6):965-73. PubMed ID: 21426114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.